Class I · High riskTerminated Initiated Jul 9, 2019 (7 years ago)
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton…
Class I — High risk. Reasonable probability of serious harm or death.
Why it was recalled
Failed dissolution specifications : failed results at the 3-month stability time point.
What was recalled
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each blister card contains 28-film coated, biconvex tablets, Rx Only, Manufactured by: Cyndea Pharma, S.L., Olvega (Soria), 42110 Spain, Distributed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801 USA, NDC 59746-763-43
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
NDC code
59746-763-43
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1837-2019
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.